Moreover, SKCM, ACC, and UCS tumor subjects exhibited the highest frequencies of NLRP1 mutations (13.96%), deep deletions (2.2%), and amplifications (3.51%), respectively. This evidence concerns the gene NLRP1 and neoplasm.